Hepatitis C drugs on Blue MedicareRx Plus (S5726-014)
Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Kansas
- Premium
- $67.40/month
- Deductible
- None
2 of 6 Hepatitis C drugs are covered on this plan. All 2 require prior authorization.
4 aren't on the formulary, including Epclusa and sofosbuvir-velpatasvir.
- 33%Tier 5
- 33%Tier 5
Not on the formulary
Epclusa, sofosbuvir-velpatasvir, Harvoni, ledipasvir-sofosbuvir
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.